Home > Newsletters > FDAnews Drug Daily Bulletin > British Drugmaker Cited for cGMP, Misbranding Violations
FDAnews Drug Daily Bulletin
Oct. 1, 2012 | Vol. 9 No. 192
British Drugmaker Cited for cGMP, Misbranding Violations
British drugmaker A Nelson has been cited in an FDA warning letter after an inspection found glass fragments in a batch of the company’s Clikpak drug vials. Nelson had not identified a corrective and preventive action plan to reduce future occurrence, according to the warning letter, posted recently online. It also failed to determine if a potentially affected product was released for distribution.
Drug GMP Report
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.